Home › Alopecia Areata › Indiana › Indianapolis
Alopecia Areata clinical trials in Indianapolis, IN
7 studies for Alopecia Areata are looking for participants at sites in and around Indianapolis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia Areata
RecruitingPhase 3
- Dawes Fretzin- Indianapolis /ID# 283498, Indianapolis
A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
RecruitingPhase 3
- Dawes Fretzin Clinical Research Group, LLC, Indianapolis
HCW9302 (Interleukin-2 Fusion Protein) for Alopecia Areata
RecruitingPhase 1
- Dawes Fretzin Clinical Research Group, Indianapolis
A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata
RecruitingPhase 3
- Dawes Fretzin Clinical Research Group, LLC, Indianapolis
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
RecruitingPhase 3
- Indiana University Health University Hospital /ID# 259827, Indianapolis
A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
RecruitingPhase 3
- Dawes Fretzin Clinical Research Group, LLC, Indianapolis
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
RecruitingPhase 3
- Dawes Fretzin Clinical Research Group Llc., Indianapolis
Alopecia Areata trials in other cities
- San Antonio, TX6 studies
- Miami, FL6 studies
- Omaha, NE5 studies
- New York City, NY4 studies
- Irvine, CA3 studies
- Troy, MI3 studies
- Columbus, OH3 studies
- Portland, OR3 studies
- Houston, TX3 studies
- Spokane, WA3 studies
- Los Angeles, CA3 studies
Other studies in Indianapolis
- Non-Small Cell Lung Cancer32 studies
- Cancer (all types)24 studies
- Heart Failure23 studies
- Breast Cancer20 studies
- Obesity20 studies
- Metastatic Cancer19 studies
- Colorectal Cancer18 studies
- Ovarian Cancer17 studies
- Lung Cancer16 studies
- Cardiovascular Disease16 studies
- Type 1 Diabetes14 studies
- Endometrial Cancer14 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.